This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Glenmark won’t be enjoined in UK from launching generic diabetes drug

( March 31, 2025, 13:40 GMT | Official Statement) -- MLex Summary: UK High Court Judge Michael Tappin has denied a bid by AstraZeneca AB and AstraZeneca UK Ltd. for an interim injunction that would bar Glenmark Pharmaceuticals Europe from proceeding with its launch of a competitor to AZ's blockbuster diabetes drug Forxiga. Both Glenmark's planned generic and Forxiga contain dapagliflozin as their active ingredient. AZ filed the underlying application after Glenmark announced its intent to introduce its product before the resolution of its related UK lawsuit against AZ, in which it seeks a declaration of patent invalidity. But Tappin said he was unconvinced that the brand drugmaker is at risk of harm which could not be adequately compensated with monetary damages alone. Tappin recommended that Glenmark pay a sum “into a separate bank account for each pack sold” between now and a hearing on injunctive relief in the validity trial.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections